<code id='382BCD9379'></code><style id='382BCD9379'></style>
      • <acronym id='382BCD9379'></acronym>
      <center id='382BCD9379'><center id='382BCD9379'><tfoot id='382BCD9379'></tfoot></center><abbr id='382BCD9379'><dir id='382BCD9379'><tfoot id='382BCD9379'></tfoot><noframes id='382BCD9379'>
      • <optgroup id='382BCD9379'><strike id='382BCD9379'><sup id='382BCD9379'></sup></strike><code id='382BCD9379'></code></optgroup>
        5. <b id='382BCD9379'><label id='382BCD9379'><select id='382BCD9379'><dt id='382BCD9379'><span id='382BCD9379'></span></dt></select></label></b><u id='382BCD9379'></u>
          <i id='382BCD9379'><strike id='382BCD9379'><tt id='382BCD9379'><pre id='382BCD9379'></pre></tt></strike></i>
          
    
          
      
          
       
      
          
        
      
          
      
          
        
          
          
          
            
          
            
          
              
          
                
          focus 
          
                
          
                
          
              
          
            
          
            
            
          
          
          
       
        
          
      
          
      
          
        
          
        
          
          
            
          
                           
          focus  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：8
                                  
                                    
          
                                    
          close-up of psoriasis on a hand. -- biotech coverage from STAT
          A close-up of psoriasis on a hand.																									Adobe 
          San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.
          Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.
          advertisement
          Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Inari Medical to buy amputation prevention company LimFlow
                                
                            
          Next article：  
                                      
                                          Medicare proposal to cover medical devices draws a mixed reaction
                                                                    
          
            
          
           
            
          
          
          
       
          
        
          
        
      
          
      
          
                                                
        
          knowledge
          
                  
          

                    
          
            
          
              
                Tori Bowie and the unacceptable rates of Black maternal death
                
          
                        
              
          
                Tori Bowie and the unacceptable rates of Black maternal death
                
          
                  
          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                Is there an 'orca uprising'? Like orcas themselves, the answer is complex.
                
          
                        
              
          
                Is there an 'orca uprising'? Like orcas themselves, the answer is complex.
                
          
                  
          8:26AgroupofBigg'skillerwhalesswimtogetherasseenfromaPacificWhaleWatchAssociationvesselonMay4,2022,n
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                Trump demands the U.S. pay no more for drugs than other countries … again
                
          
                        
              
          
                Trump demands the U.S. pay no more for drugs than other countries … again
                
          
                  
          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
         
        
          
          
        
          

          
          
            
          
          
          
            
          Gene therapy’s promise and the high cost of hope
          
            
          AdobeAtthebustlingChicagoO’Hareairport,myluggageandIcollidedwithanelderlycouple.MyheartsankwhenIreal
          
          
          
          
          
            read more